Polycythemia laboratory findings

Polycythemia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Polycythemia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography or Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Interventions
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Polycythemia laboratory findings On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Polycythemia laboratory findings All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Polycythemia laboratory findings
CDC on Polycythemia laboratory findings
Polycythemia laboratory findings in the news
Blogs on Polycythemia laboratory findings
Directions to Hospitals Treating Polycythemia
Risk calculators and risk factors for Polycythemia laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Debduti Mukhopadhyay, M.B.B.S[2]

Laboratory Findings

World Health Organization diagnostic criteria for Polycythemia Vera:

• A1 Elevated RBC mass >25% above mean normal predicted value, or Hb>18.5g/dl in men, 16.5g/dl in women
• A2 No cause of secondary Erythrocytosis include absence of familial Erythrocytosis; no elevation of erythropoietin due to hypoxia (arterial PO2</= 92%), high oxygen affinity hemoglobin, truncated erythropoietin receptors, inappropriate erythropoietin production by tumor
• A3 Splenomegaly
• A4 Clonal genetic abnormality other than Ph chromosome or BCR/ABL fusion gene in marrow cells
• A5 Endogenous erythroid colony formation in vitro
• B1 Thrombocytosis >400x10ª/L
• B2 WBC >12x10ª/L
• B3 Bone marrow biopsy showing panmyelosiswith prominent erythroid and megakaryocytic proliferation
• B4 Low serum EPO levels